Biotech fund Flagship Ventures raises $537m for biggest round yet
The venture capital fund that launched Acceleron, Moderna, and Bind Therapeutics has raised $537m (€493m) for another round of funding.
Archives for March 27, 2015
US FDA rejects Amgen bid to force biosims firms to share info before review
Biosimilar firms seeking US approval will not have to commit to share manufacturing data with reference drug firms before reviews, after the FDA rejected Amgen’s request for such a rule.
Genentech plans $125m expansion of Oregon manufacturing facility
Genentech will invest more than $125m to expand its fill/finish facility in Hillsboro, Oregon.